×
About 209,694 results

ALLMedicine™ Heart Failure Center

Research & Reviews  98,505 results

Gut dysbiosis induced by cardiac pressure overload enhances adverse cardiac remodeling ...
https://doi.org/10.1080/19490976.2020.1823801
Gut Microbes; Carrillo-Salinas FJ, Anastasiou M et. al.

Oct 26th, 2020 - Despite the existing association of gut dysbiosis and T cell inflammation in heart failure (HF), whether and how gut microbes contribute to T cell immune responses, cardiac fibrosis and dysfunction in HF remains largely unexplored. Our objective w...

A Prospective Multicentre Study of Myocardial Recovery Using Left Ventricular Assist De...
https://doi.org/10.1161/CIRCULATIONAHA.120.046415
Circulation Birks EJ, Drakos SG et. al.

Oct 26th, 2020 - Background: Left ventricular assist device (LVAD) unloading and hemodynamic support in patients with advanced chronic heart failure can result in significant improvement in cardiac function allowing LVAD removal, however the rate of this is genera...

Effects of Levosimendan on cardiac function, size and strain in heart failure patients.
https://doi.org/10.1007/s10554-020-02077-z
The International Journal of Cardiovascular Imaging; Beitzke D, Gremmel F et. al.

Oct 26th, 2020 - Levosimendan improves cardiac function in heart failure populations; however, its exact mechanism is not well defined. We analysed the short-term impact of levosimendan in heart failure patients with ischemic and non-ischemic cardiomyopathy (CMP) ...

Prognostic value of D-dimer in acute myocardial infarction complicated by heart failure...
https://doi.org/10.1002/ehf2.13027
ESC Heart Failure References; Zhang X, Wang S et. al.

Oct 26th, 2020 - The prevalence of heart failure (HF) after acute myocardial infarction (AMI) is common. Contemporary data are lacking on the prognostic utility of the measurement of biomarker for patients with AMI complicated by HF according to preserved (HFpEF) ...

Recurrent Admissions for Acute Decompensated Heart Failure Among Patients With and With...
https://doi.org/10.1161/JAHA.120.017174
Journal of the American Heart Association; Chunawala Z, Chang PP et. al.

Oct 26th, 2020 - Background Peripheral artery disease (PAD) is both a common comorbidity and a contributing factor to heart failure. Whether PAD is associated with hospitalization for recurrent decompensation among patients with established heart failure is uncert...

see more →

Guidelines  299 results

Integrated electrophysiology care for patients with heart failure: An envisioned future.
https://doi.org/10.1016/j.hrthm.2020.10.008
Heart Rhythm; Mason PK, Desai A et. al.

Oct 16th, 2020 - Integrated electrophysiology care for patients with heart failure: An envisioned future.|2020|Mason PK,Desai A,Ajijola OA,Amin AK,Barbhaiya C,|

Differential risk of incident cancer in patients with heart failure: A nationwide population-based cohort study
https://www.journal-of-cardiology.com/article/S0914-5087(20)30271-9/fulltext
Journal of Cardiology; Kwak S

Aug 25th, 2020 - Patients with heart failure (HF) are more at risk of developing cancer than the general population.

2019 AATS/ACC/SCAI/STS expert consensus systems of care document: Operator and institut...
https://doi.org/10.1016/j.jtcvs.2019.12.001
The Journal of Thoracic and Cardiovascular Surgery; , Bonow RO et. al.

Jun 16th, 2020 - 2019 AATS/ACC/SCAI/STS expert consensus systems of care document: Operator and institutional recommendations and requirements for transcatheter mitral valve intervention: A joint report of the American Association for Thoracic Surgery, the America...

Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314099
European Heart Journal; Anker SD, Butler J et. al.

Jun 4th, 2020 - The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has important implications for the safety of participants in clinical trials and the research staff caring for them and, ...

Meeting News From ACC 2020
https://www.healio.com/cardiology/meeting-news/acc-meeting
Cardiology Today;

Apr 1st, 2020 - The latest news from the ACC Annual Scientific Session, with physician perspective, researcher interviews and clinician insight on cardiovascular prevention, heart failure and more.

see more →

Drugs  2,541 results see all →

Clinicaltrials.gov  103,497 results

Gut dysbiosis induced by cardiac pressure overload enhances adverse cardiac remodeling ...
https://doi.org/10.1080/19490976.2020.1823801
Gut Microbes; Carrillo-Salinas FJ, Anastasiou M et. al.

Oct 26th, 2020 - Despite the existing association of gut dysbiosis and T cell inflammation in heart failure (HF), whether and how gut microbes contribute to T cell immune responses, cardiac fibrosis and dysfunction in HF remains largely unexplored. Our objective w...

A Prospective Multicentre Study of Myocardial Recovery Using Left Ventricular Assist De...
https://doi.org/10.1161/CIRCULATIONAHA.120.046415
Circulation Birks EJ, Drakos SG et. al.

Oct 26th, 2020 - Background: Left ventricular assist device (LVAD) unloading and hemodynamic support in patients with advanced chronic heart failure can result in significant improvement in cardiac function allowing LVAD removal, however the rate of this is genera...

Effects of Levosimendan on cardiac function, size and strain in heart failure patients.
https://doi.org/10.1007/s10554-020-02077-z
The International Journal of Cardiovascular Imaging; Beitzke D, Gremmel F et. al.

Oct 26th, 2020 - Levosimendan improves cardiac function in heart failure populations; however, its exact mechanism is not well defined. We analysed the short-term impact of levosimendan in heart failure patients with ischemic and non-ischemic cardiomyopathy (CMP) ...

Prognostic value of D-dimer in acute myocardial infarction complicated by heart failure...
https://doi.org/10.1002/ehf2.13027
ESC Heart Failure References; Zhang X, Wang S et. al.

Oct 26th, 2020 - The prevalence of heart failure (HF) after acute myocardial infarction (AMI) is common. Contemporary data are lacking on the prognostic utility of the measurement of biomarker for patients with AMI complicated by HF according to preserved (HFpEF) ...

Recurrent Admissions for Acute Decompensated Heart Failure Among Patients With and With...
https://doi.org/10.1161/JAHA.120.017174
Journal of the American Heart Association; Chunawala Z, Chang PP et. al.

Oct 26th, 2020 - Background Peripheral artery disease (PAD) is both a common comorbidity and a contributing factor to heart failure. Whether PAD is associated with hospitalization for recurrent decompensation among patients with established heart failure is uncert...

see more →

News  4,689 results

Experts Tout Immediate Quadruple Therapy for HFrEF Patients
https://www.medscape.com/viewarticle/939465

Oct 19th, 2020 - Start most patients newly diagnosed with heart failure with reduced ejection fraction on the disorder's four foundational drug regimens all at once, all on the day the diagnosis is made, Gregg C. Fonarow, MD, recommended. Less than 2 months before...

SGLT2is Lower Cardiorenal Risk in T2D Patients Without Cardiovascular and Renal Disease
https://www.medscape.com/viewarticle/939408

Oct 19th, 2020 - Takeaway Sodium-glucose cotransporter-2 inhibitors (SGLT2is) use was associated with a lower risk of heart failure (HF) and chronic kidney disease (CKD) vs dipeptidyl peptidase-4 inhibitors (DPP4is) in type 2 diabetes (T2D) patients free from card...

Entresto Halves Renal Events in Preserved EF Heart Failure Patients
https://www.medscape.com/viewarticle/939110

Oct 13th, 2020 - Patients with heart failure with preserved ejection fraction (HFpEF) who received sacubitril/valsartan in the PARAGON-HF trial had significant protection against progression of renal dysfunction in a prespecified secondary analysis. The 2419 patie...

Embracing the Right Polypharmacy in Older Adults With HF
https://www.medscape.com/viewarticle/939126

Oct 13th, 2020 - About half of older adults hospitalized with heart failure (HF) take at least 10 medications and that proportion is increasing over time, according to a new study. "I felt this was an opportunity to really outline how prevalent this issue is and a...

COVID-19: NICOR Report's Insights Into COVID and Cardiovascular Outcomes
https://www.medscape.com/viewarticle/938950

Oct 11th, 2020 - This transcript has been edited for clarity. Hi, welcome to Medscape UK. My name is Mamas Mamas. I'm professor of cardiology based at Keele University. And today we're going to focus on a publication by the National Institute of Cardiovascular Out...

see more →

Patient Education  163 results see all →